Pathology Committee Presents: 

Pathway 1: Real Life: Resolving Cause of Graft Dysfunction: DILI Is Always a Differential to Alloimmune and Other Factors

Moderated by: Laura Rubbia Brandt & Michail Doukas 

Liver Allograft Dysfunction in Patients Transplanted Following Neoadjuvant Treatment for Hepatocellular Carcinoma
Beat Moeckli & Oyedele Adeyi

Unexplained Liver Allograft Dysfunction Despite Adequate Immunosuppression
Maha Guindi

Review of Extrahepatic and Hepatic Complications of Immunosuppressive Drugs in Liver Transplant Patients
Anand Ghanekar & Mukul Vij

Pathway 2: DILI Histopathological and Emerging Diagnostic Tools in Liver Transplantation

Moderated by: Zongming Eric Chen & Mina Komuta

Pathway 2: DILI Histopathological and Emerging Diagnostic Tools in Liver Transplantation
Oyedele Adeyi & Xinyan Zhao

Panel Discussion